Establishment Labs Holdings INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Leslie Gillin, a Director of Establishment Labs Holdings Inc., received 262 shares of common stock on September 30, 2026.
NASDAQ
Edward J Schutter, a Director of Establishment Labs Holdings Inc., received 253 shares of common stock on September 30, 2026.
NASDAQ
Nicholas Sheridan Lewin, a Director of Establishment Labs Holdings Inc., received 389 shares of common stock on September 30, 2026.
NASDAQ
Bryan Slotkin, a Director of Establishment Labs Holdings Inc., received 253 shares of common stock on September 30, 2026.
NASDAQ
Ann Custin, a Director of Establishment Labs Holdings Inc., received 301 shares of common stock on September 30, 2026.
NASDAQ
Filippo Caldini, Chief Executive Officer and a Director of Establishment Labs Holdings Inc., reported a transaction in 682 shares of common stock on August 20, 2026.
NASDAQ
Juan Jose Chacon Quiros, a Director at ESTA, acquired 11,315 common shares through an equity incentive plan award.
NASDAQ
Nicholas Sheridan Lewin, a Director at Establishment Labs Holdings Inc. (ESTA), reported the acquisition of stock options on April 24, 2026.
NASDAQ
Taylor C. Harris, a Director at ESTABLISHMENT LABS HOLDINGS INC., reported the acquisition of stock units under the company's 2018 Equity Incentive Plan.
NASDAQ
Director Leslie Gillin acquired 196 shares of Establishment Labs Holdings Inc. common stock on June 30, 2026, as part of the Outside Director Compensation Policy.
NASDAQ
Ann Custin, a Director at Establishment Labs Holdings Inc., received 239 common shares as a quarterly retainer payment, valued at $85.81 per share.
NASDAQ
Director Nicholas Sheridan Lewin acquired 291 common shares of Establishment Labs Holdings Inc. (ESTA) valued at $85.81 each, electing to receive shares instead of a cash retainer.
NASDAQ
Edward J. Schutter, a Director at Establishment Labs Holdings Inc., received 216 common shares as a substitute for his quarterly cash retainer payment.
NASDAQ
Bryan Slotkin, a Director at Establishment Labs Holdings Inc., received common shares valued at $85.81 per share as a quarterly retainer payment.
NASDAQ
Establishment Labs Holdings Inc. reports that Director Taylor C. Harris was awarded stock units under the 2018 Equity Incentive Plan, with vesting schedules detailed.
NASDAQ
JW Asset Management and affiliated entities have sold a portion of their holdings in Establishment Labs, dropping their beneficial ownership below the 10% threshold.
NASDAQ
ESTA Director Bryan Slotkin acquired 2,354 stock units under the Issuer's 2018 Equity Incentive Plan, with vesting scheduled for May 22, 2027, or the day before the next annual meeting.
NASDAQ
Edward J. Schutter, a Director at Establishment Labs Holdings Inc. (ESTA), has acquired 2,354 common shares through an equity award.
NASDAQ
Director Ann Custin reported an acquisition of 2,354 common shares in Establishment Labs Holdings Inc. (ESTA) on May 22, 2026, under an equity incentive plan.
NASDAQ
Establishment Labs Holdings Inc. reports a stock unit award to Director Nicholas Sheridan Lewin under the 2018 Equity Incentive Plan.
NASDAQ
JW Asset Management, led by Jason G. Wild, sold a total of 20,579 shares of Establishment Labs Holdings Inc. across two days in May 2026.
NASDAQ
Director Juan Jose Chacon Quiros sold 105,000 shares of Establishment Labs Holdings Inc. via a 10b5-1 trading plan.
NASDAQ
JW Asset Management, LLC and affiliated entities reported the sale of 60,000 common shares of Establishment Labs Holdings Inc.
NASDAQ
Director Juan Jose Chacon Quiros sold 75,000 shares of Establishment Labs Holdings Inc. via a Rule 10b5-1 trading plan.
NASDAQ
Director Juan Jose Chacon Quiros sold 75,000 shares of Establishment Labs Holdings Inc. via a Rule 10b5-1 trading plan.
NASDAQ
Director Juan Jose Chacon Quiros sold 37,500 shares of Establishment Labs Holdings Inc. via a 10b5-1 trading plan.
NASDAQ
Filippo Caldini, CEO and Director of Establishment Labs Holdings Inc., reported transactions involving common shares and stock options.
NASDAQ
Director Edward J. Schutter of Establishment Labs Holdings Inc. reported the acquisition of 36,780 common shares through the exercise of stock options.
NASDAQ
Establishment Labs Holdings Director Leslie Gillin acquired 297 common shares in lieu of a cash retainer, increasing her beneficial ownership to 16,044 shares.
NASDAQ
Establishment Labs Director Bryan Slotkin acquired 286 common shares, increasing his direct beneficial ownership to 30,256 shares.